HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preproinsulin specific CD8+ T cells in subjects with latent autoimmune diabetes show lower frequency and different pathophysiological characteristics than those with type 1 diabetes.

Abstract
Latent autoimmune diabetes in adults (LADA) resembles type 1 diabetes (T1D) in disease presentation except that its onset is slow. We compared pathophysiological characteristics of CD8+ T cells recognizing preproinsulin (PPI) derived epitopes in both disease groups using MHC-I dextramers (DMRs) in peripheral blood and after in-vitro stimulation with PPI. Subjects with T1D harbored higher frequency of DMR+ CD8+ T cells with relatively higher frequency of effector T cell subsets. Following stimulation with PPI, an increase in DMR+ CD8+ T cells, particularly the central-memory subset was observed in T1D group, whereas no significant change in DMR+ CD8+ T cell subsets was observed in LADA group. Intracellular expression of Granzyme-B and Perforin in DMR+ CD8+ T cells was comparable in both the groups. In conclusion, lower frequency and inferior proliferative potential on account of a relatively restrained central-memory subset of PPI specific CD8+ T cells are associated with slow rate of disease progression in LADA.
AuthorsNaresh Sachdeva, Mahinder Paul, Darshan Badal, Rajendra Kumar, Neenu Jacob, Devi Dayal, Anil Bhansali, Sunil Kumar Arora, Sanjay Kumar Bhadada
JournalClinical immunology (Orlando, Fla.) (Clin Immunol) Vol. 157 Issue 1 Pg. 78-90 (Mar 2015) ISSN: 1521-7035 [Electronic] United States
PMID25597827 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Insulin
  • Protein Precursors
  • preproinsulin
Topics
  • Adult
  • Asymptomatic Diseases
  • CD8-Positive T-Lymphocytes (immunology, pathology)
  • Child
  • Diabetes Mellitus, Type 1 (immunology, physiopathology)
  • Female
  • Humans
  • Insulin (metabolism)
  • Male
  • Protein Precursors (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: